Recent News

• 03.10.2025 - Leerink Partners 2025 Global Healthcare Conference
• 03.04.2025 - TD Cowen 45th Annual Health Care Conference
• 02.27.2025 - Amicus Therapeutics to Present at Upcoming Investor Conferences in March 2025
• 02.27.2025 - Amicus Therapeutics to Present at Upcoming Investor Conferences in March 2025
• 02.19.2025 - Amicus Fourth Quarter & Full Year 2024 Results Conference Call and Webcast
• 02.19.2025 - Amicus Therapeutics Announces Full-Year 2024 Financial Results and Corporate Updates
• 02.19.2025 - Amicus Therapeutics Announces Full-Year 2024 Financial Results and Corporate Updates

Recent Filings

• 02.21.2025 - 4 Statement of changes in beneficial ownership of securities
• 02.21.2025 - 424B5 Prospectus [Rule 424(b)(5)]
• 02.21.2025 - 8-K Current report
• 02.19.2025 - 144 Report of proposed sale of securities
• 02.19.2025 - 10-K Annual report [Section 13 and 15(d), not S-K Item 405]
• 02.19.2025 - 8-K Current report
• 02.19.2025 - S-3ASR Automatic shelf registration statement of securities of well-known seasoned issuers
• 02.19.2025 - EX-99.1 EX-99.1
• 02.14.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 02.14.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors